American Integrity Insurance Group Launches New Commercial Residential Property Program in Florida
TAMPA, Fla.–(BUSINESS WIRE)–American Integrity Insurance Group, Inc. (NYSE: AII) (“American Integrity” or the “Company”), a leading provider... Read more.
Fortive Schedules Third Quarter 2025 Earnings Conference Call
EVERETT, Wash.–(BUSINESS WIRE)–Fortive Corporation (“Fortive”) (NYSE: FTV) today announced that it will webcast its earnings conference call for... Read more.
Harvest Announces New Harvest Enhanced High Income Shares ETFs Listings on the TSX
OAKVILLE, Ontario–(BUSINESS WIRE)–Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce the completion of the initial offering of Class... Read more.
Investindustrial’s Windoria Announces Strategic Acquisition of Al-Fursan, Marking a Major Milestone in Saudi Partnership and Regional Expansion
LONDON–(BUSINESS WIRE)–Windoria, indirectly owned by affiliated funds managed or advised by Investindustrial, entered into an agreement to acquire Al-Fursan... Read more.
Enterra Solutions Earns Numerous Best-in-Class Category Distinctions for the Fourth Consecutive Year In Promotion Optimization Institute’s 2025 Consumer Goods Vendor Panorama
Enterra solidifies its position as a definitive leader in autonomous enterprise optimization, with consistent excellence spanning 2022-2025 PRINCETON, N.J.–(BUSINESS... Read more.
Gregory & Appel Launches Vertical Practices to Enhance Client Experience and Advance Future Growth
INDIANAPOLIS–(BUSINESS WIRE)–#alternativerisk–Gregory & Appel Insurance (G&A), a nationally recognized independent insurance and risk advisory... Read more.
Kwanti Wins WealthManagement.com Industry Award for Portfolio Analytics for Second Consecutive Year
Kwanti also named a finalist in the ThinkAdvisor 2025 Luminaries Awards SAN FRANCISCO–(BUSINESS WIRE)–#Kitces–For the second year in a row, Kwanti,... Read more.
ENHERTU® Followed by THP Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk HER2 Positive Early-Stage Breast Cancer Prior to Surgery
Based on results from DESTINY-Breast11, the first phase 3 trial to demonstrate benefit of Daiichi Sankyo and AstraZeneca’s ENHERTU in early-stage breast cancer... Read more.
Boppy® Just Dropped the ComfyHold and Parents Are About to Be OBSESSED
GOLDEN, Colo.–(BUSINESS WIRE)–#boppy–Parents already know the hip carry. It’s the go-to move when your toddler wants up, but your arms and back... Read more.
Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease Fast Track Designation... Read more.